The negative effect of platelet-rich plasma on the growth of human cells is associated with secreted thrombospondin-1

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 107, Issue 2, 2009, Pages 185-192

  Hsu, Chia Wen ^a   Yuan, Kuo ^b   Tseng, Chuen Chyi ^c  

^a TAINAN MUNICIPAL HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; THROMBOSPONDIN 1;

ADULT; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; COCULTURE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; FIBROBLAST; HUMAN; MALE; MIDDLE AGED; OSTEOBLAST; PERIODONTAL LIGAMENT; REGENERATION; THROMBOCYTE COUNT; THROMBOCYTE RICH PLASMA; UMBILICAL VEIN;

ADULT; ANGIOGENESIS INHIBITORS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; FEMALE; FIBROBLASTS; HUMANS; MALE; MIDDLE AGED; OSTEOBLASTS; PERIODONTAL LIGAMENT; PLATELET COUNT; PLATELET-RICH PLASMA; REGENERATION; THROMBOSPONDIN 1; UMBILICAL VEINS; YOUNG ADULT;

EID: 58149462224     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2008.07.016     Document Type: Article

References (45)

1. Marx R.E., Carlson E.R., Eichstaedt R.M., Schimmele S.R., Strauss J.E., and Georgeff K.R. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85 (1998) 638-646
2. Anitua E. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants 14 (1999) 529-535
3. Camargo P.M., Lekovic V., Weinlaender M., Vasilic N., Madzarevic M., and Kenney E.B. Platelet-rich plasma and bovine porous bone mineral combined with guided tissue regeneration in the treatment of intrabony defects in humans. J Periodontal Res 37 (2002) 300-306
4. van den Dolder J., Mooren R., Vloon A.P., Stoelinga P.J., and Jansen J.A. Platelet-rich plasma: quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells. Tissue Eng 12 (2006) 3067-3073
5. Pierce G.F., Mustoe T.A., Atrock B.W., Deuel T.F., and Tomason A. Role of platelet-derived growth factor in wound healing. J Cell Biochem 45 (1991) 319-326
6. Rudkin G.H., and Miller T.A. Growth factors in surgery. J Plast Reconstr Surg 97 (1996) 469-476
7. Panagakos F.S. Insulin-like growth factors-I and -II stimulate chemotaxis of osteoblasts isolated from fetal rat calvaria. Biochimie 75 (1993) 991-994
8. Aghallo T.L., Moy P.K., and Freymiller E.G. Investigation of platelet-rich plasma in rabbit cranial defects: a pilot study. J Oral Maxillofac Surg 60 (2002) 1176-1181
9. Froum S.J., Wallace S.S., Tarnow D.P., and Cho S.C. Effect of platelet-rich plasma on bone growth and osseointegration in human maxillary sinus grafts: three bilateral case reports. Int J Periodontics Restorative Dent 22 (2002) 45-53
10. Fuerst G., Gruber R., Tangl S., Sanroman F., and Watzek G. Effects of fibrin sealant protein concentrate with and without platelet-released growth factors on bony healing of cortical mandibular defects. An experimental study in minipigs. Clin Oral Implants Res 15 (2004) 301-307
11. Raghoebar G.M., Schortinghuis J., Liem R., Ruben J.L., Van Der Wal J.E., and Vissink A. Does platelet-rich plasma promote remodeling of autologous bone grafts used for augmentation of the maxillary sinus floor?. Clin Oral Implants Res 16 (2005) 349-356
12. Döri F., Huszár T., Nikolidakis D., Arweiler N.B., Gera I., and Sculean A. Effect of platelet-rich plasma on the healing of intra-bony defects treated with a natural bone mineral and a collagen membrane. J Clin Periodontol 34 (2007) 254-261
13. You T.M., Choi B.H., Li J., Jung J.H., Lee H.J., Lee S.H., et al. The effect of platelet-rich plasma on bone healing around implants placed in bone defects treated with Bio-Oss: a pilot study in the dog tibia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 (2007) e8-e12
14. Plachokova A.S., van den Dolder J., Stoelinga P.J., and Jansen J.A. Early effect of platelet-rich plasma on bone healing in combination with an osteoconductive material in rat cranial defects. Clin Oral Implants Res 18 (2007) 244-251
15. Dawes J., Clemetson K.J., Gogstad G.O., McGregor J., Clezardin P., Prowse C.V., et al. A radioimmunoassay for thrombospondin, used in a comparative study of thrombospondin, beta-thromboglobulin and platelet factor 4 in healthy volunteers. Thromb Res 29 (1983) 569-581
16. Switalska H.I., Niewiarowski S., Tuszynski G.P., Rucinski B., Schmaier A.H., Morinelli T.A., et al. Radioimmunoassay of human platelet thrombospondin: different patterns of thrombospondin and beta-thromboglobulin antigen secretion and clearance from the circulation. J Lab Clin Med 106 (1985) 690-700
17. Baenziger N.L., Brodie G.N., and Majerus P.W. A thrombin-sensitive protein of human platelet membranes. Proc Natl Acad Sci U S A 68 (1971) 240-243
18. Baenziger N.L., Brodie G.N., and Majerus P.W. Isolation and properties of a thrombin-sensitive protein of human platelets. J Biol Chem 247 (1972) 2723-2731
19. Adams J.C. Thrombospondins: multifunctional regulators of cell interactions. Ann Rev Cell Dev Biol 17 (2001) 25-51
20. Margossian S., Lawler J.W., and Slayter H.S. Physical characterization of platelet thrombospondin. J Biol Chem 256 (1981) 7495-7500
21. Coligan J.E., and Slayter H.S. Structure of thrombospondin. J Biol Chem 259 (1984) 3944-3948
22. Lawler J., Derick L.H., Connolly J.E., Chen J.H., and Chao F.C. The structure of human platelet thrombospondin. J Biol Chem 260 (1985) 3762-3772
23. Bornstein P., and Sage E.H. Thrombospondins. Methods Enzymol 245 (1994) 62-85
24. Iruela-Arispe M.L., Lombardo M., Krutzsch H.C., Lawler J., and Roberts D.D. Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats. Circulation 100 (1999) 1423-1431
25. Panetti T.S., Chen H., Misenheimer T.M., Getzler S.B., and Mosher D.F. Endothelial cell mitogenesis induced inhibition by thrombospondin-1 and thrombospondin-2 by LPA. J Lab Clin Med 129 (1997) 208-216
26. Armstrong L.C., and Bornstein P. Thrombospondins 1 and 2 function as inhibitors of angiogenesis. Matrix Biol 22 (2003) 63-71
27. Somerman M.J., Archer S.Y., Imm G.R., and Foster R.A. A comparative study of human periodontal ligament cells and gingival fibroblasts in vitro. J Dent Res 67 (1988) 66-70
28. Jaffe E.A., Nachman R.L., Becker C.G., and Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52 (1973) 2745-2756
29. Mills D.C., Robb I.A., and Roberts G.C. The release of nucleotides, 5-hydroxytryptamine and enzymes from human blood platelets during aggregation. J Physiol 195 (1968) 715-729
30. Graziani F., Ivanovski S., Cei S., Ducci F., Tonetti M., and Gabriele M. The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts. Clin Oral Implants Res 17 (2006) 212-221
31. Disdier M., Legrand C., Bouillot C., Dubernard V., Pidard D., and Nurden A.T. Quantitation of platelet fibrinogen and thrombospondin in Glanzmann's thrombasthenia by electroimmunoassay. Thromb Res 53 (1989) 521-533
32. Weibrich G., Kleis W.K.G., and Hafner G. Growth factor levels in the platelet-rich plasma produced by 2 different methods: curasan-type PRP kit versus PCCS PRP system. Int J Oral Maxillofac Implants 17 (2002) 184-190
33. Okuda K., Kawase T., Momose M., Murata M., Saito Y., Suzuki H., et al. Platelet-rich plasma contains high levels of platelet-derived growth factor and transforming growth factor-β and modulates the proliferation of periodontally related cells in vitro. J Periodontol 74 (2003) 849-857
34. Eppley B.L., Woodell J.E., and Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg 114 (2004) 1502-1508
35. Brown K.J., Maynes S.F., Bezos A., Maguire D.J., Ford M.D., and Parish C.R. A novel in vitro assay for human angiogenesis. Lab Invest 75 (1996) 539-555
36. Diegelmann R.F., and Evans M.C. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci 9 (2004) 283-289
37. O'Brien J., Wilson I., Ortaon T., and Pognan F. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 267 (2000) 5421-5426
38. Choi B.H., Zhu S.J., Kim B.Y., Huh J.Y., Lee S.H., and Jung J.H. Effect of platelet-rich plasma (PRP) concentration on the viability and proliferation of alveolar bone cells: an in vitro study. Int J Oral Maxillofac Surg 34 (2005) 420-424
39. Pillitteri D., Bassus S., Boller K., Mahnel R., Scholz T., Westrup D., et al. Thrombin-induced interleukin 1 beta synthesis in platelet suspensions: impact of contaminating leukocytes. Platelets 18 (2007) 119-127
40. Dayan S., Stashenko P., Niederman R., and Kupper T.S. Oral epithelial overexpression of IL-1alpha causes periodontal disease. J Dent Res 83 (2004) 786-790
41. Gustafsson A., Ito H., Asman B., and Bergstrom K. Hyper-reactive mononuclear cells and neutrophils in chronic periodontitis. J Clin Periodontol 33 (2006) 126-129
42. Orozco A., Gemmell E., Bickel M., and Seymour G.J. Interleukin-1beta, interleukin-12 and interleukin-18 levels in gingival fluid and serum of patients with gingivitis and periodontitis. Oral Microbiol Immunol 21 (2006) 250-260
43. Eley B.M., and Cox S.W. Advances in periodontal diagnosis. 7. Proteolytic and hydrolytic enzymes link with periodontitis. Br Dent J 184 (1998) 323-328
44. Layik M., Yamalik N., Caglayan F., Kilinc K., Etikan I., and Eratalay K. Analysis of human gingival tissue and gingival crevicular fluid beta-glucuronidase activity in specific periodontal diseases. J Periodontol 71 (2000) 618-624
45. Chesney C.M., Harper E., and Colman R.W. Human platelet collagenase. J Clin Invest 53 (1974) 1647-1654